The progression of next-generation sequencing (NGS) from research to clinical laboratories is helping to bring the long-awaited goal of personalized medicine one step closer.
Learn more about the Illumina IVD high throughput sequencing instrument. The NovaSeq™ 6000Dx offers operational simplicity and the flexibility of sequencing in either IVD or research use only (RUO) mode. Paired with the DRAGEN™ platform, this high throughput solution enables streamlined data handling, delivers faster file transfers, and reduces data storage costs.
Download the article to learn more about how NGS will drive personalized medicine.
For In Vitro Diagnostic Use. Not available in all regions and countries.
Image Credit: Illumina, Inc
About Illumina, Inc
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.